• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于吉非替尼和阿霉素共递送的功能化大孔介孔二氧化硅微粒

Functionalized Large-Pore Mesoporous Silica Microparticles for Gefitinib and Doxorubicin Codelivery.

作者信息

Li Yan, Song Fangxiang, Cheng Liang, Qian Jin, Chen Qianlin

机构信息

Institute of Advanced Technology, Guizhou University, Guiyang 550025, China.

School of Chemistry and Chemical Engineering, Guizhou University, Guiyang 550025, China.

出版信息

Materials (Basel). 2019 Mar 6;12(5):766. doi: 10.3390/ma12050766.

DOI:10.3390/ma12050766
PMID:30845677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6427430/
Abstract

Large-pore coralline mesoporous silica microparticles (CMS) were synthesized using the triblock polymer PEG--PEO--PEG and a hydrothermal method. Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) revealed the coralline morphology of the fabricated materials. The Brunauer⁻Emmett⁻Teller (BET) method and the Barrett⁻Joyner⁻Halenda (BJH) model confirmed the existence of large pores (20 nm) and of a tremendous specific surface area (663.865 m²·g) and pore volume (0.365 cm³·g). A novel pH-sensitive multiamine-chain carboxyl-functionalized coralline mesoporous silica material (CMS⁻(NH)₃⁻COOH) was obtained via a facile "grafting-to" approach. X-ray photoelectron spectroscopy (XPS) and Fourier-transform infrared spectroscopy (FT-IR) validated the effective interfacial functionalization of CMS with carboxyl and multiamine chains. The encapsulation and release behavior of the dual drug (gefitinib (GB) and doxorubicin (DOX)) was also investigated. It was found that CMS⁻(NH)₃⁻COOH allows rapid encapsulation with a high loading capacity of 47.36% for GB and 26.74% for DOX. Furthermore, the release profiles reveal that CMS⁻(NH)₃⁻COOH can preferably control the release of DOX and GB. The accumulative release rates of DOX and GB were 32.03% and 13.66%, respectively, at a low pH (pH 5.0), while they reduced to 8.45% and 4.83% at pH 7.4. Moreover, all of the modified silica nanoparticles exhibited a high biocompatibility with a low cytotoxicity. In particular, the cytotoxicity of both of these two drugs was remarkably reduced after being encapsulated. CMS⁻(NH)₃⁻COOH@GB@DOX showed tremendously synergistic effects of the dual drug in the antiproliferation and apoptosis of A549 human cancer cells in vitro.

摘要

采用三嵌段聚合物聚乙二醇-聚环氧乙烷-聚乙二醇(PEG-PEO-PEG)和水热法合成了大孔珊瑚状介孔二氧化硅微粒(CMS)。扫描电子显微镜(SEM)和透射电子显微镜(TEM)揭示了所制备材料的珊瑚状形态。布鲁诺尔-埃米特-泰勒(BET)法和巴雷特-乔伊纳-哈伦达(BJH)模型证实了大孔(20 nm)的存在以及巨大的比表面积(663.865 m²·g)和孔体积(0.365 cm³·g)。通过简便的“接枝到”方法获得了一种新型的pH敏感型多胺链羧基功能化珊瑚状介孔二氧化硅材料(CMS-(NH)₃-COOH)。X射线光电子能谱(XPS)和傅里叶变换红外光谱(FT-IR)验证了CMS与羧基和多胺链的有效界面功能化。还研究了双药(吉非替尼(GB)和阿霉素(DOX))的包封和释放行为。发现CMS-(NH)₃-COOH能够快速包封,对GB的高负载量为47.36%,对DOX的高负载量为26.74%。此外,释放曲线表明CMS-(NH)₃-COOH能够较好地控制DOX和GB的释放。在低pH(pH 5.0)下,DOX和GB的累积释放率分别为32.03%和13.66%,而在pH 7.4时分别降至8.45%和4.83%。此外,所有改性二氧化硅纳米颗粒均表现出高生物相容性和低细胞毒性。特别是,这两种药物在包封后细胞毒性均显著降低。CMS-(NH)₃-COOH@GB@DOX在体外对A549人癌细胞的增殖抑制和凋亡方面显示出双药的巨大协同效应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/8467331687f2/materials-12-00766-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/b1c1386738e3/materials-12-00766-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/fb679505b702/materials-12-00766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/d81ae45a18fb/materials-12-00766-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/ba7116743a77/materials-12-00766-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/c418c1573a25/materials-12-00766-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/dd57dd521d1e/materials-12-00766-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/81774572cb4a/materials-12-00766-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/b44ecb949bd2/materials-12-00766-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/aad8cf3be56b/materials-12-00766-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/e31b8b4a98c1/materials-12-00766-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/8467331687f2/materials-12-00766-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/b1c1386738e3/materials-12-00766-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/fb679505b702/materials-12-00766-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/d81ae45a18fb/materials-12-00766-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/ba7116743a77/materials-12-00766-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/c418c1573a25/materials-12-00766-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/dd57dd521d1e/materials-12-00766-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/81774572cb4a/materials-12-00766-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/b44ecb949bd2/materials-12-00766-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/aad8cf3be56b/materials-12-00766-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/e31b8b4a98c1/materials-12-00766-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba8e/6427430/8467331687f2/materials-12-00766-sch002.jpg

相似文献

1
Functionalized Large-Pore Mesoporous Silica Microparticles for Gefitinib and Doxorubicin Codelivery.用于吉非替尼和阿霉素共递送的功能化大孔介孔二氧化硅微粒
Materials (Basel). 2019 Mar 6;12(5):766. doi: 10.3390/ma12050766.
2
The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.通过二硫键连接子功能化的不同聚乙二醇链长度的介孔二氧化硅纳米颗粒的性质及其在谷胱甘肽介质中的药物释放。
J Biomater Sci Polym Ed. 2016;27(1):55-68. doi: 10.1080/09205063.2015.1107708. Epub 2015 Nov 5.
3
Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.羧基功能化介孔硅纳米粒子用于控制递释难溶性非甾体抗炎药物。
Acta Biomater. 2021 Oct 15;134:576-592. doi: 10.1016/j.actbio.2021.07.023. Epub 2021 Jul 17.
4
Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.聚多巴胺包覆的中空介孔二氧化硅纳米粒子作为用于克服多药耐药性的pH敏感纳米载体。
Colloids Surf B Biointerfaces. 2019 Nov 1;183:110427. doi: 10.1016/j.colsurfb.2019.110427. Epub 2019 Aug 6.
5
DPP-Cu Complexes Gated Mesoporous Silica Nanoparticles For pH and Redox Dual Stimuli-Responsive Drug Delivery.DPP-Cu 配合物介孔硅纳米粒子用于 pH 和氧化还原双重刺激响应药物传递。
Curr Med Chem. 2023;30(28):3249-3260. doi: 10.2174/0929867329666221011110504.
6
Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).介孔二氧化硅的合成、氨基官能化及其对Cr(VI)的吸附
J Colloid Interface Sci. 2008 Feb 15;318(2):309-14. doi: 10.1016/j.jcis.2007.09.093. Epub 2007 Oct 9.
7
and Bioimaging Studies of Mesoporous Silica Nanocomposites Encapsulated Iron-oxide and Loaded Doxorubicin Drug (DOX/IO@Silica) as Magnetically Guided Drug Delivery System.介孔硅纳米复合材料封装氧化铁和负载阿霉素药物(DOX/IO@Silica)的磁共振成像和生物成像研究及其作为磁导向药物传递系统。
Curr Pharm Biotechnol. 2023;24(10):1297-1306. doi: 10.2174/1389201023666220428084920.
8
Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by FeO/carboxyl functionalized mesoporous SiO hybrid nanoparticles: A-synthesis, physicochemical and biological characterization.柠檬酸功能化硅烷偶联与接枝后策略用于通过 FeO/羧基功能化介孔 SiO2 杂化纳米粒子双重 pH 和盐响应递送顺铂:A-合成、物理化学和生物学表征。
Mater Sci Eng C Mater Biol Appl. 2019 Nov;104:109922. doi: 10.1016/j.msec.2019.109922. Epub 2019 Jun 27.
9
Preparation and in-vitro evaluation of mesoporous biogenic silica nanoparticles obtained from rice and wheat husk as a biocompatible carrier for anti-cancer drug delivery.以稻壳和麦壳为原料制备介孔生物源二氧化硅纳米颗粒并进行体外评价,作为抗癌药物递送的生物相容性载体
Eur J Pharm Sci. 2021 Aug 1;163:105866. doi: 10.1016/j.ejps.2021.105866. Epub 2021 May 4.
10
TPGS-Functionalized Polydopamine-Modified Mesoporous Silica as Drug Nanocarriers for Enhanced Lung Cancer Chemotherapy against Multidrug Resistance.TPGS 功能化聚多巴胺修饰的介孔硅作为药物纳米载体用于增强肺癌化疗对多药耐药性的作用。
Small. 2017 Aug;13(29). doi: 10.1002/smll.201700623. Epub 2017 Jun 8.

引用本文的文献

1
Whey Protein Isolate as a Substrate to Design Flower Extract Controlled-Release Materials.乳清蛋白分离物作为设计花提取物控释材料的基质。
Int J Mol Sci. 2024 May 13;25(10):5325. doi: 10.3390/ijms25105325.
2
Leukocyte/platelet hybrid membrane-camouflaged dendritic large pore mesoporous silica nanoparticles co-loaded with photo/chemotherapeutic agents for triple negative breast cancer combination treatment.负载光/化疗药物的白细胞/血小板杂化膜伪装的树枝状大孔介孔二氧化硅纳米粒子用于三阴性乳腺癌联合治疗
Bioact Mater. 2021 Apr 13;6(11):3865-3878. doi: 10.1016/j.bioactmat.2021.04.004. eCollection 2021 Nov.

本文引用的文献

1
Reduction and pH dual-sensitive nanovesicles co-delivering doxorubicin and gefitinib for effective tumor therapy.还原与pH双重敏感的纳米囊泡共递送阿霉素和吉非替尼用于有效的肿瘤治疗。
RSC Adv. 2018 Jan 9;8(4):2082-2091. doi: 10.1039/c7ra12620d. eCollection 2018 Jan 5.
2
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 29 种癌症组别的伤残调整生命年数,1990 年至 2016 年:全球疾病负担研究的系统分析。
JAMA Oncol. 2018 Nov 1;4(11):1553-1568. doi: 10.1001/jamaoncol.2018.2706.
3
A simple reduction-sensitive micelles co-delivery of paclitaxel and dasatinib to overcome tumor multidrug resistance.
一种简单的还原敏感型胶束共递送紫杉醇和达沙替尼以克服肿瘤多药耐药性。
Int J Nanomedicine. 2017 Nov 1;12:8043-8056. doi: 10.2147/IJN.S148273. eCollection 2017.
4
Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy.吉非替尼和阿霉素延迟顺序共递送用于靶向联合化疗。
Mol Pharm. 2017 Dec 4;14(12):4551-4559. doi: 10.1021/acs.molpharmaceut.7b00669. Epub 2017 Nov 7.
5
TPGS-Functionalized Polydopamine-Modified Mesoporous Silica as Drug Nanocarriers for Enhanced Lung Cancer Chemotherapy against Multidrug Resistance.TPGS 功能化聚多巴胺修饰的介孔硅作为药物纳米载体用于增强肺癌化疗对多药耐药性的作用。
Small. 2017 Aug;13(29). doi: 10.1002/smll.201700623. Epub 2017 Jun 8.
6
Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy.通过含达沙替尼的氧化还原响应性聚合物前药载体递送多柔比星用于联合治疗。
J Control Release. 2017 Jul 28;258:43-55. doi: 10.1016/j.jconrel.2017.05.006. Epub 2017 May 12.
7
Effective melanoma cancer suppression by iontophoretic co-delivery of STAT3 siRNA and imatinib using gold nanoparticles.利用金纳米颗粒通过离子电渗法共递送STAT3小干扰RNA和伊马替尼实现有效的黑色素瘤抑制
Int J Pharm. 2017 Jun 20;525(2):407-417. doi: 10.1016/j.ijpharm.2017.03.087. Epub 2017 Apr 1.
8
Charge-Reversal APTES-Modified Mesoporous Silica Nanoparticles with High Drug Loading and Release Controllability.荷正电 APTES 修饰的介孔硅纳米粒子具有高载药率和可控释放能力。
ACS Appl Mater Interfaces. 2016 Jul 13;8(27):17166-75. doi: 10.1021/acsami.6b05370. Epub 2016 Jun 28.
9
PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy.聚乙二醇化脂质双层支撑的介孔二氧化硅纳米颗粒复合物用于阿昔替尼和雷公藤红素在多靶点癌症治疗中的协同共递送
Acta Biomater. 2016 Jul 15;39:94-105. doi: 10.1016/j.actbio.2016.05.012. Epub 2016 May 6.
10
Dual-pH responsive micelle platform for co-delivery of axitinib and doxorubicin.双 pH 响应胶束平台用于阿昔替尼和多柔比星的共递送。
Int J Pharm. 2016 Jun 30;507(1-2):50-60. doi: 10.1016/j.ijpharm.2016.04.060. Epub 2016 May 3.